Jane Street Group, LLC Heron Therapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	SELL	$4.63 - $9.94 $418,089 - $897,582	-90,300 Reduced 75.56%	29,200 $167,000
Q4 2021 Feb 15, 2022	BUY	$8.35 - $12.6 $819,135 - $1.24 Million	98,100 Added 458.41%	119,500 $1.09 Million
Q3 2021 Nov 16, 2021	SELL	$10.13 - $15.0 $70,910 - $105,000	-7,000 Reduced 24.65%	21,400 $229,000
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $135,354 - $188,496	10,200 Added 56.04%	28,400 $441,000
Q1 2021 May 18, 2021	BUY	$14.49 - $20.72 $92,736 - $132,608	6,400 Added 54.24%	18,200 $295,000
Q3 2020 Nov 17, 2020	SELL	$13.67 - $17.77 $451,110 - $586,410	-33,000 Reduced 73.66%	11,800 $175,000
Q2 2020 Aug 17, 2020	BUY	$10.89 - $21.47 $487,872 - $961,856	44,800 New	44,800 $659,000

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $188M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.